Dr. Freeman received his medical degree from Jefferson Medical College and completed his internship and residency in surgery, as well as his fellowship in transplantation, through the Harvard Surgical Service at BIDMC (formerly known as New England Deaconess Hospital). Dr. Freeman received his master’s degree in Healthcare Leadership (MHL) from Brown University in 2020. Among his numerous academic achievements, he has participated as Principal Investigator in 30 clinical trials, and has been author on more than 300 peer-reviewed articles, book chapters and abstracts.
- Thomas Jefferson University, MD
- Franklin & Marshall College, BA
- Brown University, MHL
- Published on 7/3/2023
Vega EA, Agudile E, Salirrosas O, Chirban AM, Brauner E, Crocker A, Freeman R, Sorescu GP, Odisio BC, Conrad C. Clinical outcomes and cost of open, laparoscopic, and percutaneous ablation for hepatocellular carcinoma. J Surg Oncol. 2023 Oct; 128(5):812-822. PMID: 37395114.
- Published on 6/10/2023
Chirban AM, Vega EA, Kutlu OC, Mellado S, Kozyreva O, Zauls AJ, Panettieri E, Salirrosas O, Freeman R, Conrad C. R1 pancreatic cancer patients benefit from chemoradiation when initiation of adjuvant therapy is delayed. Surg Oncol. 2023 Aug; 49:101961. PMID: 37321066.
- Published on 2/8/2023
Panettieri E, Vega EA, Chirban AM, Salirrosas O, Clancy TE, Malek A, Freeman R, Conrad C. Anatomic Laparoscopic Partial Hepatectomy of a Segment 4a B-Catenin Mutated Adenoma. Ann Surg Oncol. 2023 Jul; 30(7):4234-4235. PMID: 36752966.
- Published on 5/4/2022
Mellado S, Vega EA, Abudalou M, Kutlu OC, Salehi O, Li M, Kozyreva O, Freeman R, Conrad C. Trends in Preoperative Chemotherapy Utilization for Proximal Pancreatic Cancer: Are We Making Progress? J Gastrointest Surg. 2022 Aug; 26(8):1-7. PMID: 35508681.
- Published on 4/8/2022
Salehi O, Vega EA, Mellado S, Core MJ, Li M, Kozyreva O, Kutlu OC, Freeman R, Conrad C. High-Quality Surgery for Gallbladder Carcinoma: Rare, Associated with Disparity, and Not Substitutable by Chemotherapy. J Gastrointest Surg. 2022 Jun; 26(6):1241-1251. PMID: 35396641.
- Published on 3/10/2022
Vega EA, Mellado S, Salehi O, Freeman R, Conrad C. Treatment of Resectable Gallbladder Cancer. Cancers (Basel). 2022 Mar 10; 14(6). PMID: 35326566.
- Published on 12/16/2021
Vega EA, Kutlu OC, Salehi O, Alarcon SV, Abudalou M, Kozyreva O, Krishnan S, Lee D, Freeman R, Conrad C. The impact of chemotherapy sequencing on resectable pancreatic cancer by stage. Surg Oncol. 2022 Mar; 40:101694. PMID: 34973593.
- Published on 12/10/2021
Salehi O, Vega EA, Kutlu OC, Lunsford K, Freeman R, Ladin K, Alarcon SV, Kazakova V, Conrad C. Poorly differentiated hepatocellular carcinoma: resection is equivalent to transplantation in patients with low liver fibrosis. HPB (Oxford). 2022 Jul; 24(7):1100-1109. PMID: 34969618.
- Published on 11/8/2021
Salehi O, Kazakova V, Vega EA, Kutlu OC, Alarcon SV, Freeman R, Kozyreva O, Conrad C. Selection criteria for minimally invasive resection of intrahepatic cholangiocarcinoma-a word of caution: a propensity score matched analysis using the national cancer database. Surg Endosc. 2022 Jul; 36(7):5382-5391. PMID: 34750709.
- Published on 9/22/2021
Ruf A, Dirchwolf M, Freeman RB. From Child-Pugh to MELD score and beyond: Taking a walk down memory lane. Ann Hepatol. 2022 Jan-Feb; 27(1):100535. PMID: 34560316.
View 184 more publications: View full profile at BUMC